IGF1 and cancer: Additionally, epidemiological studies (8) in the general population have shown an association between increased circulating levels of GH’s central mediator, Insulin-like Growth Factor 1 (IGF-1), and certain types of cancer, underscoring the importance of remaining vigilant to this potential risk.